ProQR Therapeutics (PRQR) Current Assets (2021 - 2024)
Historic Current Assets for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $164.4 million.
- ProQR Therapeutics' Current Assets rose 2629.13% to $164.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $164.4 million, marking a year-over-year increase of 2629.13%. This contributed to the annual value of $166.5 million for FY2024, which is 2723.23% up from last year.
- Latest data reveals that ProQR Therapeutics reported Current Assets of $164.4 million as of Q4 2024, which was up 2629.13% from $130.2 million recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics' Current Assets ranged from a high of $219.1 million in Q4 2021 and a low of $87893.6 during Q1 2021
- Its 4-year average for Current Assets is $150.3 million, with a median of $157.6 million in 2022.
- Data for ProQR Therapeutics' Current Assets shows a peak YoY increase of 22013299.48% (in 2022) and a maximum YoY decrease of 4972.96% (in 2022) over the last 5 years.
- ProQR Therapeutics' Current Assets (Quarter) stood at $219.1 million in 2021, then decreased by 28.06% to $157.6 million in 2022, then decreased by 17.4% to $130.2 million in 2023, then grew by 26.29% to $164.4 million in 2024.
- Its Current Assets was $164.4 million in Q4 2024, compared to $130.2 million in Q4 2023 and $135.7 million in Q3 2023.